Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.
Yamazaki Y, Usui I, Kanatani Y, Matsuya Y, Tsuneyama K, Fujisaka S, Bukhari A, Suzuki H, Senda S, Imanishi S, Hirata K, Ishiki M, Hayashi R, Urakaze M, Nemoto H, Kobayashi M, Tobe K. Yamazaki Y, et al. Among authors: kobayashi m. Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1179-86. doi: 10.1152/ajpendo.90997.2008. Epub 2009 Sep 1. Am J Physiol Endocrinol Metab. 2009. PMID: 19724016 Free article.
Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice.
Fujisaka S, Usui I, Kanatani Y, Ikutani M, Takasaki I, Tsuneyama K, Tabuchi Y, Bukhari A, Yamazaki Y, Suzuki H, Senda S, Aminuddin A, Nagai Y, Takatsu K, Kobayashi M, Tobe K. Fujisaka S, et al. Among authors: kobayashi m. Endocrinology. 2011 May;152(5):1789-99. doi: 10.1210/en.2010-1312. Epub 2011 Mar 22. Endocrinology. 2011. PMID: 21427223
Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.
Usui I, Fujisaka S, Yamazaki K, Takano A, Murakami S, Yamazaki Y, Urakaze M, Hachiya H, Takata M, Senda S, Iwata M, Satoh A, Sasaoka T, Ak ND, Temaru R, Kobayashi M. Usui I, et al. Among authors: kobayashi m. Diabetes Res Clin Pract. 2007 Aug;77(2):210-4. doi: 10.1016/j.diabres.2006.11.014. Epub 2007 Jan 19. Diabetes Res Clin Pract. 2007. PMID: 17240472 Clinical Trial.
Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
Ishizuka K, Usui I, Kanatani Y, Bukhari A, He J, Fujisaka S, Yamazaki Y, Suzuki H, Hiratani K, Ishiki M, Iwata M, Urakaze M, Haruta T, Kobayashi M. Ishizuka K, et al. Among authors: kobayashi m. Endocrinology. 2007 Jun;148(6):2994-3003. doi: 10.1210/en.2006-1702. Epub 2007 Mar 22. Endocrinology. 2007. PMID: 17379643
Angiotensin II enhances the increase in monocyte chemoattractant protein-1 production induced by tumor necrosis factor-{alpha} from 3T3-L1 preadipocytes.
Asamizu S, Urakaze M, Kobashi C, Ishiki M, Norel Din AK, Fujisaka S, Kanatani Y, Bukahari A, Senda S, Suzuki H, Yamazaki Y, Iwata M, Usui I, Yamazaki K, Ogawa H, Kobayashi M, Tobe K. Asamizu S, et al. Among authors: kobayashi m. J Endocrinol. 2009 Aug;202(2):199-205. doi: 10.1677/JOE-08-0363. Epub 2009 May 8. J Endocrinol. 2009. PMID: 19429670
[Rabson-Mendenhall syndrome].
Ishiki M, Kobayashi M. Ishiki M, et al. Among authors: kobayashi m. Nihon Rinsho. 2002 Sep;60 Suppl 9:804-8. Nihon Rinsho. 2002. PMID: 12387088 Review. Japanese. No abstract available.
12,166 results
You have reached the last available page of results. Please see the User Guide for more information.